Stifel Raises Price Target After Inogen (INGN) Reports Better-Than-Expected 1Q

May 10, 2016 9:48 AM

Stifel reiterated a Buy rating on Inogen, Inc (NASDAQ: INGN), and raised the price target to $52.00 (from $46.00), following ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found